(Q53808742)

20 May 2018

reason for preferred rank

title

Treatment of Parkinson’s Disease with Amantadine and L-Dopa (English)

1 reference

https://api.crossref.org/works/10.1159/000114429

3 February 2023

Treatment of Parkinson's disease with amantadine and L-Dopa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4556618

3 February 2023

1 reference

1 reference

https://api.crossref.org/works/10.1159/000114429

3 February 2023

1

U K Rinne

1 reference

20 May 2018

author name string

U. K. Rinne

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4556618

3 February 2023

V. Sonninen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4556618

3 February 2023

T. Siirtola

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4556618

3 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4556618

3 February 2023

publication date

1 January 1972

1 reference

20 May 2018

full work available at URL

https://www.karger.com/Article/Pdf/114429

1 reference

https://api.crossref.org/works/10.1159/000114429

3 February 2023

1 reference

20 May 2018

volume

7

1 reference

20 May 2018

issue

4

1 reference

20 May 2018

page(s)

228-240

1 reference

20 May 2018

Identifiers

DOI

10.1159/000114429

1 reference

20 May 2018

1 reference

20 May 2018